CCL7 and IRF-7 mediate hallmark inflammatory and IFN responses following rhinovirus 1B infection

Journal of Immunology

Volumn 194, Issue 10, 2015, Pages 4924-4930

  Girkin, Jason ^a   Hatchwell, Luke ^a   Foster, Paul ^a   Johnston, Sebastian L ^b   Bartlett, Nathan ^b   Collison, Adam ^a   Mattes, Joerg ^a,c  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c Paediatric Respiratory and Sleep Medicine Unit Newcastle Children's Hospital   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CCL7 ANTIBODY; CYTOKINE ANTIBODY; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERFERON REGULATORY FACTOR 7; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 3; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RELA; TRANSCRIPTOME; UNCLASSIFIED DRUG; CCL7 PROTEIN, MOUSE; IRF7 PROTEIN, MOUSE;

ALLERGY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BAGG ALBINO MOUSE; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; CYTOKINE RESPONSE; DISEASE EXACERBATION; EOSINOPHIL; IN VIVO STUDY; INFLAMMATION; MACROPHAGE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RHINOVIRUS 1B INFECTION; RHINOVIRUS INFECTION; SIGNAL TRANSDUCTION; UPREGULATION; VIRUS STRAIN; ANIMAL; COMMON COLD; DISEASE MODEL; FLOW CYTOMETRY; IMMUNOLOGY; LUNG; REAL TIME POLYMERASE CHAIN REACTION; RHINOVIRUS; VIROLOGY;

ANIMALS; BRONCHIAL HYPERREACTIVITY; CHEMOKINE CCL7; COMMON COLD; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; INFLAMMATION; INTERFERON REGULATORY FACTOR-7; INTERFERONS; LUNG; MALE; MICE; MICE, INBRED BALB C; NF-KAPPA B; REAL-TIME POLYMERASE CHAIN REACTION; RHINOVIRUS; TRANSCRIPTOME;

EID: 84929119018     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401362     Document Type: Article

References (38)

1. Khetsuriani, N., N. N. Kazerouni, D. D. Erdman, X. Lu, S. C. Redd, L. J. Anderson, and W. G. Teague. 2007. Prevalence of viral respiratory tract infections in children with asthma. J. Allergy Clin. Immunol. 119: 314-321.
2. Rueter, K., J. Bizzintino, A. C. Martin, G. Zhang, C. M. Hayden, G. C. Geelhoed, J. Goldblatt, I. A. Laing, and P. N. Le Souëf. 2012. Symptomatic viral infection is associated with impaired response to treatment in children with acute asthma. J. Pediatr. 160: 82-87.
3. Busse, W. W. 2010. The relationship of airway hyperresponsiveness and airway inflammation: Airway hyperresponsiveness in asthma: its measurement and clinical significance. Chest 138(2, Suppl.): 4S-10S.
4. Busse, W. W., R. F. Lemanske, Jr., and J. E. Gern. 2010. Role of viral respiratory infections in asthma and asthma exacerbations. Lancet 376: 826-834.
5. Fahy, J. V., K. W. Kim, J. Liu, and H. A. Boushey. 1995. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J. Allergy Clin. Immunol. 95: 843-852.
6. Kelly, J. T., and W. W. Busse. 2008. Host immune responses to rhinovirus: mechanisms in asthma. J. Allergy Clin. Immunol. 122: 671-682.
7. Alexopoulou, L., A. C. Holt, R. Medzhitov, and R. A. Flavell. 2001. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 413: 732-738.
8. Kawai, T., and S. Akira. 2007. Antiviral signaling through pattern recognition receptors. J. Biochem. 141: 137-145.
9. Luster, A. D. 2001. Antichemokine immunotherapy for allergic diseases. Curr. Opin. Allergy Clin. Immunol. 1: 561-567.
10. Hatchwell, L., J. Girkin, M. D. Dun, M. Morten, N. Verrills, H. D. Toop, J. C. Morris, S. L. Johnston, P. S. Foster, A. Collison, and J. Mattes. 2014. Salmeterol attenuates chemotactic responses in rhinovirus-induced exacerbation of allergic airways disease by modulating protein phosphatase 2A. J. Allergy Clin. Immunol. 133: 1720-1727.
11. Collison, A., L. Hatchwell, N. Verrills, P. A. Wark, A. Pereira de Siqueira, M. Tooze, H. Carpenter, A. S. Don, J. C. Morris, N. Zimmermann, et al. 2013. The E3 ubiquitin ligase midline 1 promotes allergen and rhinovirus-induced asthma by inhibiting protein phosphatase 2A activity. Nat. Med. 19: 232-237.
12. Bartlett, N. W., R. P. Walton, M. R. Edwards, J. Aniscenko, G. Caramori, J. Zhu, N. Glanville, K. J. Choy, P. Jourdan, J. Burnet, et al. 2008. Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation. Nat. Med. 14: 199-204.
13. H2 cells and the expression of allergic airway disease. Nat. Med. 13: 1308-1315.
14. H2 mediated allergic airways disease and rhinovirus exacerbation. PLoS ONE 8: e79565. Available at: http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0079565.
15. Collison, A., J. Li, A. Pereira de Siqueira, J. Zhang, H. D. Toop, J. C. Morris, P. S. Foster, and J. Mattes. 2014. Tumor necrosis factor-related apoptosis-inducing ligand regulates hallmark features of airways remodeling in allergic airways disease. Am. J. Respir. Cell Mol. Biol. 51: 86-93.
16. Zeldin, D. C., C. Wohlford-Lenane, P. Chulada, J. A. Bradbury, P. E. Scarborough, V. Roggli, R. Langenbach, and D. A. Schwartz. 2001. Airway inflammation and responsiveness in prostaglandin H synthase-deficient mice exposed to bacterial lipopolysaccharide. Am. J. Respir. Cell Mol. Biol. 25: 457-465.
17. Mattes, J., A. Collison, M. Plank, S. Phipps, and P. S. Foster. 2009. Antagonism of microRNA-126 suppresses the effector function of TH2 cells and the development of allergic airways disease. Proc. Natl. Acad. Sci. USA 106: 18704-18709.
18. Souto, F. O., J. C. Alves-Filho, W. M. Turato, M. Auxiliadora-Martins, A. Basile-Filho, and F. Q. Cunha. 2011. Essential role of CCR2 in neutrophil tissue infiltration and multiple organ dysfunction in sepsis. Am. J. Respir. Crit. Care Med. 183: 234-242.
19. Chung, I. Y., Y. H. Kim, M. K. Choi, Y. J. Noh, C. S. Park, D. Y. Kwon, D. Y. Lee, Y. S. Lee, H. S. Chang, and K. S. Kim. 2004. Eotaxin and monocyte chemotactic protein-3 use different modes of action. Biochem. Biophys. Res. Commun. 314: 646-653.
20. Michalec, L., B. K. Choudhury, E. Postlethwait, J. S. Wild, R. Alam, M. Lett-Brown, and S. Sur. 2002. CCL7 and CXCL10 orchestrate oxidative stressinduced neutrophilic lung inflammation. J. Immunol. 168: 846-852.
21. Mercer, P. F., A. E. Williams, C. J. Scotton, R. J. José, M. Sulikowski, J. D. Moffatt, L. A. Murray, and R. C. Chambers. 2014. Proteinase-activated receptor-1, CCL2, and CCL7 regulate acute neutrophilic lung inflammation. Am. J. Respir. Cell Mol. Biol. 50: 144-157.
22. Powell, N., M. Humbert, S. R. Durham, B. Assoufi, A. B. Kay, and C. J. Corrigan. 1996. Increased expression of mRNA encoding RANTES and MCP-3 in the bronchial mucosa in atopic asthma. Eur. Respir. J. 9: 2454-2460.
23. Schneider, D., J. Y. Hong, E. R. Bowman, Y. Chung, D. R. Nagarkar, C. L. McHenry, A. M. Goldsmith, J. K. Bentley, T. C. Lewis, and M. B. Hershenson. 2013. Macrophage/epithelial cell CCL2 contributes to rhinovirus-induced hyperresponsiveness and inflammation in a mouse model of allergic airways disease. Am. J. Physiol. Lung Cell. Mol. Physiol. 304:L162-L169.
24. Desmet, C., P. Gosset, B. Pajak, D. Cataldo, M. Bentires-Alj, P. Lekeux, and F. Bureau. 2004. Selective blockade of NF-κB activity in airway immune cells inhibits the effector phase of experimental asthma. J. Immunol. 173: 5766-5775.
25. Kuperman, D. A., X. Huang, L. L. Koth, G. H. Chang, G. M. Dolganov, Z. Zhu, J. A. Elias, D. Sheppard, and D. J. Erle. 2002. Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat. Med. 8: 885-889.
26. Mattes, J., M. Yang, A. Siqueira, K. Clark, J. MacKenzie, A. N. McKenzie, D. C. Webb, K. I. Matthaei, and P. S. Foster. 2001. IL-13 induces airways hyperreactivity independently of the IL-4Rα chain in the allergic lung. J. Immunol. 167: 1683-1692.
27. Webb, D. C., A. N. McKenzie, A. M. Koskinen, M. Yang, J. Mattes, and P. S. Foster. 2000. Integrated signals between IL-13, IL-4, and IL-5 regulate airways hyperreactivity. J. Immunol. 165: 108-113.
28. Yang, M., S. P. Hogan, P. J. Henry, K. I. Matthaei, A. N. McKenzie, I. G. Young, M. E. Rothenberg, and P. S. Foster. 2001. Interleukin-13 mediates airways hyperreactivity through the IL-4 receptor-α chain and STAT-6 independently of IL-5 and eotaxin. Am. J. Respir. Cell Mol. Biol. 25: 522-530.
29. Mattes, J., M. Yang, S. Mahalingam, J. Kuehr, D. C. Webb, L. Simson, S. P. Hogan, A. Koskinen, A. N. McKenzie, L. A. Dent, et al. 2002. Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hyperreactivity in experimental asthma. J. Exp. Med. 195: 1433-1444.
30. Torres, R., A. Herrerias, M. Serra-Pagès, J. Roca-Ferrer, L. Pujols, A. Marco, C. Picado, and F. de Mora. 2008. An intranasal selective antisense oligonucleotide impairs lung cyclooxygenase-2 production and improves inflammation, but worsens airway function, in house dust mite sensitive mice. Respir. Res. 9: 72.
31. Santiago, J., J. L. Hernández-Cruz, M. E. Manjarrez-Zavala, R. Montes-Vizuet, D. P. Rosete-Olvera, A. M. Tapia-Díaz, H. Zepeda-Peney, and L. M. Terán. 2008. Role of monocyte chemotactic protein-3 and -4 in children with virus exacerbation of asthma. Eur. Respir. J. 32: 1243-1249.
32. Thackray, L. B., E. Duan, H. M. Lazear, A. Kambal, R. D. Schreiber, M. S. Diamond, and H. W. Virgin. 2012. Critical role for interferon regulatory factor 3 (IRF-3) and IRF-7 in type I interferon-mediated control of murine norovirus replication. J. Virol. 86: 13515-13523.
33. Chen, H. W., K. King, J. Tu, M. Sanchez, A. D. Luster, and S. Shresta. 2013. The roles of IRF-3 and IRF-7 in innate antiviral immunity against dengue virus. J. Immunol. 191: 4194-4201.
34. Honda, K., H. Yanai, H. Negishi, M. Asagiri, M. Sato, T. Mizutani, N. Shimada, Y. Ohba, A. Takaoka, N. Yoshida, and T. Taniguchi. 2005. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 434: 772-777.
35. Honda, K., and T. Taniguchi. 2006. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat. Rev. Immunol. 6: 644-658.
36. Wang, J., B. Yang, Y. Hu, Y. Zheng, H. Zhou, Y. Wang, Y. Ma, K. Mao, L. Yang, G. Lin, et al. 2013. Negative regulation of Nmi on virus-triggered type I IFN production by targeting IRF7. J. Immunol. 191: 3393-3399.
37. Lewis, T. C., T. A. Henderson, A. R. Carpenter, I. A. Ramirez, C. L. McHenry, A. M. Goldsmith, X. Ren, G. B. Mentz, B. Mukherjee, T. G. Robins, et al. 2012. Nasal cytokine responses to natural colds in asthmatic children. Clin. Exp. Allergy 42: 1734-1744.
38. Cohen, M., O. Matcovitch, E. David, Z. Barnett-Itzhaki, H. Keren-Shaul, R. Blecher-Gonen, D. A. Jaitin, A. Sica, I. Amit, and M. Schwartz. 2014. Chronic exposure to TGFβ1 regulates myeloid cell inflammatory response in an IRF7-dependent manner. EMBO J. 33: 2906-2921.